[
  {
    "text": "After helping develop the first\ninsulin therapy in 1921,",
    "start": 7.045,
    "duration": 3.461
  },
  {
    "text": "Canadian physician Frederick Banting\ntransferred his patent rights",
    "start": 10.631,
    "duration": 3.671
  },
  {
    "text": "to the University of Toronto for $1,",
    "start": 14.302,
    "duration": 2.419
  },
  {
    "text": "stating that insulin belonged\nto the world— not to him.",
    "start": 16.721,
    "duration": 3.045
  },
  {
    "text": "A century later, insulin medications\nremain essential in treating diabetes,",
    "start": 19.974,
    "duration": 4.338
  },
  {
    "text": "and have relatively low production costs,",
    "start": 24.312,
    "duration": 1.96
  },
  {
    "text": "with a vial generally costing\nless than $6 to make.",
    "start": 26.272,
    "duration": 3.42
  },
  {
    "text": "But how much it costs a patient to buy\nvaries greatly by country.",
    "start": 29.859,
    "duration": 3.67
  },
  {
    "text": "Those in the US may pay thousands\nfor insulin annually—",
    "start": 33.571,
    "duration": 3.42
  },
  {
    "text": "on average 10 times more than those\nin many other countries—",
    "start": 37.075,
    "duration": 3.294
  },
  {
    "text": "leading some patients to take\nless than prescribed.",
    "start": 40.453,
    "duration": 2.669
  },
  {
    "text": "And this is part of a much larger trend.",
    "start": 43.247,
    "duration": 2.127
  },
  {
    "text": "Let’s take a look at the US drug\nsupply chain to understand why.",
    "start": 45.458,
    "duration": 3.712
  },
  {
    "text": "First, there’s research and development,",
    "start": 49.545,
    "duration": 2.002
  },
  {
    "text": "which ranges widely in cost,\ndepending on the drug.",
    "start": 51.547,
    "duration": 3.003
  },
  {
    "text": "Expenses incurred by the many drugs\nthat don’t make it to market",
    "start": 54.675,
    "duration": 3.337
  },
  {
    "text": "also need to be factored in here.",
    "start": 58.012,
    "duration": 1.835
  },
  {
    "text": "And almost every approved drug\nhas been subsidized by taxes.",
    "start": 60.056,
    "duration": 3.92
  },
  {
    "text": "Before pharmaceutical companies\nactually release a drug,",
    "start": 64.352,
    "duration": 3.044
  },
  {
    "text": "they set its price.",
    "start": 67.396,
    "duration": 1.335
  },
  {
    "text": "Historically, they haven't been required\nto justify the pricing they land on.",
    "start": 68.815,
    "duration": 4.087
  },
  {
    "text": "Pharmaceutical companies are also allowed\nterms of drug patent protection",
    "start": 73.653,
    "duration": 3.753
  },
  {
    "text": "and exclusivity rights that prevent\nother manufacturers",
    "start": 77.406,
    "duration": 3.003
  },
  {
    "text": "from launching identical drugs\nfor a set period of time.",
    "start": 80.409,
    "duration": 3.17
  },
  {
    "text": "Once patents expire, competition\nusually causes prices to drop,",
    "start": 83.788,
    "duration": 3.879
  },
  {
    "text": "so some companies invest heavily\nto extend their patents.",
    "start": 87.75,
    "duration": 3.295
  },
  {
    "text": "They may make tweaks—",
    "start": 91.129,
    "duration": 1.251
  },
  {
    "text": "like small changes in dosage\nand modes of delivery—",
    "start": 92.38,
    "duration": 2.794
  },
  {
    "text": "to obtain new patents and sue competitors ",
    "start": 95.174,
    "duration": 2.419
  },
  {
    "text": "into delaying the release\nof similar drugs.",
    "start": 97.593,
    "duration": 2.211
  },
  {
    "text": "The companies responsible for Humira,\nthe best-selling autoimmune drug,",
    "start": 99.929,
    "duration": 3.921
  },
  {
    "text": "for example, have defended its patents\nand raised its price 27 times since 2003.",
    "start": 103.85,
    "duration": 5.964
  },
  {
    "text": "Without insurance, it can cost\nover $96,000 a year.",
    "start": 109.939,
    "duration": 4.213
  },
  {
    "text": "And as three pharmaceutical companies\nhave dominated the insulin market",
    "start": 114.402,
    "duration": 3.462
  },
  {
    "text": "with similar tactics,",
    "start": 117.864,
    "duration": 1.293
  },
  {
    "text": "average insulin list prices have tripled\nover the last two decades.",
    "start": 119.157,
    "duration": 4.379
  },
  {
    "text": "Once a drug is approved, there are two\nmain distribution channels it can take:",
    "start": 124.37,
    "duration": 3.921
  },
  {
    "text": "the retail route includes drugs\nyou pick up at pharmacies;",
    "start": 128.291,
    "duration": 3.128
  },
  {
    "text": "the other consists of drugs administered\nat hospitals and clinics.",
    "start": 131.419,
    "duration": 3.503
  },
  {
    "text": "This includes many of the more expensive,",
    "start": 134.964,
    "duration": 2.211
  },
  {
    "text": "research-intensive therapies\nfor rare conditions.",
    "start": 137.175,
    "duration": 2.752
  },
  {
    "text": "Each channel involves unique businesses.",
    "start": 140.052,
    "duration": 2.461
  },
  {
    "text": "Most drugs— including insulin—\nfollow the retail channel.",
    "start": 143.014,
    "duration": 3.587
  },
  {
    "text": "It starts with a pharmaceutical company\nselling the drug to wholesalers,",
    "start": 146.684,
    "duration": 3.545
  },
  {
    "text": "which buy in bulk and sell to pharmacies,\nwhich sell to patients.",
    "start": 150.229,
    "duration": 3.837
  },
  {
    "text": "But the US doesn't provide\nuniversal health care,",
    "start": 154.15,
    "duration": 2.544
  },
  {
    "text": "so many Americans use health insurance.",
    "start": 156.736,
    "duration": 2.377
  },
  {
    "text": "When an insured patient picks\nup their prescription,",
    "start": 159.28,
    "duration": 2.461
  },
  {
    "text": "they often pay a portion while the\npharmacy bills their insurer the rest.",
    "start": 161.741,
    "duration": 3.712
  },
  {
    "text": "Pharmacy benefit managers,\nor PBMs,",
    "start": 165.912,
    "duration": 2.627
  },
  {
    "text": "which are companies unique\nto the US market,",
    "start": 168.539,
    "duration": 2.294
  },
  {
    "text": "negotiate on behalf of insurers to get\ndiscounts from manufacturers",
    "start": 170.875,
    "duration": 4.129
  },
  {
    "text": "in exchange for insurance coverage.",
    "start": 175.004,
    "duration": 2.252
  },
  {
    "text": "PBMs may pass some of the\nnegotiated discount to insurers—",
    "start": 177.34,
    "duration": 3.545
  },
  {
    "text": "but they may also take\na considerable portion.",
    "start": 181.01,
    "duration": 2.419
  },
  {
    "text": "Their role tends to limit patient choice,",
    "start": 183.596,
    "duration": 2.336
  },
  {
    "text": "and they’ve sometimes covered more\nexpensive branded drugs",
    "start": 185.932,
    "duration": 2.794
  },
  {
    "text": "instead of cheaper generics because\nit earns them a greater profit.",
    "start": 188.726,
    "duration": 3.629
  },
  {
    "text": "Without insurance, patients may be\nexpected to foot the bill entirely,",
    "start": 192.563,
    "duration": 3.712
  },
  {
    "text": "at non-negotiated rates.",
    "start": 196.275,
    "duration": 1.835
  },
  {
    "text": "Money flows between the different\nbusinesses as fees, rebates, discounts,",
    "start": 198.527,
    "duration": 4.13
  },
  {
    "text": "and copay assistance. ",
    "start": 202.657,
    "duration": 1.418
  },
  {
    "text": "If it feels hard to follow,\nthat's because it is.",
    "start": 204.283,
    "duration": 2.753
  },
  {
    "text": "And it's tough to know exactly\nhow much money goes where",
    "start": 207.161,
    "duration": 2.836
  },
  {
    "text": "because these transactions\nlack transparency.",
    "start": 209.997,
    "duration": 2.67
  },
  {
    "text": "But for insulin in 2018, of all that\nwas spent on the medication:",
    "start": 213.0,
    "duration": 3.963
  },
  {
    "text": "manufacturers received about 46%;\nwholesalers got about 8%; pharmacies, 20%;",
    "start": 217.046,
    "duration": 6.548
  },
  {
    "text": "insurance companies, 10%;\nand PBMs, 14%.",
    "start": 223.803,
    "duration": 4.379
  },
  {
    "text": "Interestingly, as insulin list prices\nincreased between 2014 and 2018,",
    "start": 228.474,
    "duration": 5.047
  },
  {
    "text": "the amount manufacturers\nretained decreased,",
    "start": 233.604,
    "duration": 2.795
  },
  {
    "text": "and more than half went to intermediaries.",
    "start": 236.399,
    "duration": 2.586
  },
  {
    "text": "Where the US has businesses negotiate\nat various steps,",
    "start": 239.36,
    "duration": 2.961
  },
  {
    "text": "other countries generally have government\nagencies evaluate a drug’s benefit,",
    "start": 242.321,
    "duration": 4.213
  },
  {
    "text": "make bulk purchases, and regulate pricing.",
    "start": 246.659,
    "duration": 2.544
  },
  {
    "text": "The US sees the most drug development—\nand profit— of any country.",
    "start": 249.37,
    "duration": 3.754
  },
  {
    "text": "But about 1 in 4 Americans reported\ntrouble affording prescriptions in 2019.",
    "start": 253.207,
    "duration": 4.588
  },
  {
    "text": "Many experts have called for measures\nlike increased regulation",
    "start": 258.337,
    "duration": 2.962
  },
  {
    "text": "in drug pricing, patenting,\nand intermediary profits,",
    "start": 261.299,
    "duration": 3.294
  },
  {
    "text": "along with more national health\nand research funding.",
    "start": 264.593,
    "duration": 2.628
  },
  {
    "text": "This way, the US could\nideally lower prices",
    "start": 267.263,
    "duration": 3.045
  },
  {
    "text": "and encourage more innovative,\nlifesaving drug development.",
    "start": 270.308,
    "duration": 3.003
  },
  {
    "text": "And by making medications affordable,",
    "start": 273.352,
    "duration": 2.002
  },
  {
    "text": "pharmaceutical companies could\ntheoretically maintain profits.",
    "start": 275.354,
    "duration": 3.42
  },
  {
    "text": "In 2023, one of the largest insulin\nmanufacturers announced",
    "start": 279.317,
    "duration": 4.045
  },
  {
    "text": "it would substantially decrease\nthe drug’s list price,",
    "start": 283.362,
    "duration": 2.836
  },
  {
    "text": "and two others followed suit.",
    "start": 286.198,
    "duration": 1.877
  },
  {
    "text": "This should make insulin more affordable.",
    "start": 288.659,
    "duration": 2.419
  },
  {
    "text": "But system-wide changes would\nhave to be instated",
    "start": 291.078,
    "duration": 2.586
  },
  {
    "text": "to make sure patients are getting\nthe medications they need.",
    "start": 293.664,
    "duration": 3.587
  }
]